Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors

In a new study, NIH investigators found that patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal blood cancer. The study, which used population-based data, was published in JAMA Oncology.

https://ift.tt/2PO4cRv